Effect of probiotics in peritoneal dialysis patients

Not Applicable

• Conditions: Other dialysis; ephropathy.

• Registration Number: IRCT2017031329812N3
• Lead Sponsor: Vice Chancellor for research of University of Medical Sciences and Health Services, Yazd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Inclusion critera: uremic patients on peritoneal dialysis for three months and more, older than 15 years. Exclusion criteria: uremic patients with advanced malignancy, uremic patients with an interval of at least three months from the last peritonitis episodes, uremic patients with active infectious disease, uremic patients with uncontrolled autoimmune diseases such as lupus

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CRP-Hs. Timepoint: At baseline and Two months after the initiation of trial. Method of measurement: dl/g.;ESR. Timepoint: At baseline and Two months after the initiation of trial. Method of measurement: mm/h.